Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP7594458B2 - Antibacterial resin molded product and its manufacturing method - Google Patents
[go: Go Back, main page]

JP7594458B2 - Antibacterial resin molded product and its manufacturing method - Google Patents

Antibacterial resin molded product and its manufacturing method Download PDF

Info

Publication number
JP7594458B2
JP7594458B2 JP2021023185A JP2021023185A JP7594458B2 JP 7594458 B2 JP7594458 B2 JP 7594458B2 JP 2021023185 A JP2021023185 A JP 2021023185A JP 2021023185 A JP2021023185 A JP 2021023185A JP 7594458 B2 JP7594458 B2 JP 7594458B2
Authority
JP
Japan
Prior art keywords
antibacterial
cavity
raw material
resin
molded product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021023185A
Other languages
Japanese (ja)
Other versions
JP2022125544A (en
Inventor
信二 杉江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inoac Corp
Original Assignee
Inoac Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inoac Corp filed Critical Inoac Corp
Priority to JP2021023185A priority Critical patent/JP7594458B2/en
Publication of JP2022125544A publication Critical patent/JP2022125544A/en
Application granted granted Critical
Publication of JP7594458B2 publication Critical patent/JP7594458B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Injection Moulding Of Plastics Or The Like (AREA)

Description

本発明は、抗菌性樹脂成形品およびその製造方法に関する。 The present invention relates to an antibacterial resin molded product and a method for producing the same.

特許文献1などにより、抗菌剤入りの抗菌性樹脂成形品が知られている。 Antibacterial resin molded products containing antibacterial agents are known, for example from Patent Document 1.

日本国特開平9-216563号公報Japanese Patent Application Publication No. 9-216563

ところで、上記特許文献は、金型のキャビティ面に予め抗菌層を形成した後、型内に樹脂を流し込んで抗菌性樹脂成形品を製造する方法が記載されている。この場合、金型キャビティ面に形成した抗菌層は、樹脂を流し込んだ際に、抗菌層が流れて取れてしまう可能性がある。
また、他の抗菌性樹脂成形品は、抗菌剤を含む樹脂を用いて、射出成型で成形されることも多い。しかしこのような方法では、表面に露出した抗菌剤のみが抗菌性に寄与するものの、樹脂内に埋没した抗菌剤は抗菌性に寄与せず、抗菌作用に関与しない抗菌剤が多量に存在することになる。このため、抗菌剤の利用効率が悪い。
また、有機系の抗菌剤は射出成型時の熱によって変質してしまうので、有機系の抗菌剤を用いることができない。
Incidentally, the above-mentioned patent document describes a method for producing an antibacterial resin molded product by forming an antibacterial layer on the cavity surface of a mold in advance and then pouring a resin into the mold. In this case, there is a possibility that the antibacterial layer formed on the cavity surface of the mold will be washed away when the resin is poured in.
Other antibacterial resin molded products are often made by injection molding using resins containing antibacterial agents. However, in this method, only the antibacterial agent exposed on the surface contributes to the antibacterial properties, while the antibacterial agent buried in the resin does not contribute to the antibacterial properties, resulting in a large amount of antibacterial agent that does not participate in the antibacterial action. This results in poor utilization efficiency of the antibacterial agent.
In addition, organic antibacterial agents cannot be used because they are altered by the heat during injection molding.

本発明は、無機系および有機系いずれの抗菌剤を用いることができ、かつ、抗菌剤の利用効率の高められた抗菌性樹脂成形品およびその製造方法を提供することを目的とする。 The present invention aims to provide an antibacterial resin molded product that can use either inorganic or organic antibacterial agents and has improved utilization efficiency of the antibacterial agent, and a method for producing the same.

本発明の一態様によれば、
熱可塑性樹脂製の本体部と、前記本体部の表面の少なくとも一部に設けられた抗菌層と、を有する抗菌性樹脂成形品の製造方法であって、
上下に開閉する上型および第一下型を型閉じして前記本体部を形成するための第一キャビティを形成し、前記第一キャビティに熱可塑性樹脂を流し込み、
型閉じした前記上型および前記第一下型内で前記熱可塑性樹脂を冷却固化させて前記本体部を成形し、
前記上型に前記本体部を保持させながら、前記上型および前記第一下型を型開きさせ、
前記第一下型を前記上型に保持された前記本体部の温度より低温にした第二下型と交換し、
前記上型および前記第二下型を型閉じして、前記本体部と前記第二下型との間に前記抗菌層を形成するための第二キャビティを形成し、
前記第二キャビティ内に、無機系または有機系の抗菌剤を含む液状のウレタン樹脂原料を流し込み、
前記第二下型を加熱して前記ウレタン樹脂原料を硬化させて前記抗菌層を形成する、抗菌性樹脂成形品の製造方法が提供される。
According to one aspect of the present invention,
A method for producing an antibacterial resin molded product having a thermoplastic resin body and an antibacterial layer provided on at least a portion of a surface of the body, comprising:
An upper mold and a first lower mold that open and close vertically are closed to form a first cavity for forming the main body portion, and a thermoplastic resin is poured into the first cavity;
The thermoplastic resin is cooled and solidified within the closed upper mold and the first lower mold to mold the main body portion;
While the main body portion is held by the upper die, the upper die and the first lower die are opened;
replacing the first lower die with a second lower die whose temperature is lower than the temperature of the main body portion held by the upper die;
The upper mold and the second lower mold are closed to form a second cavity for forming the antibacterial layer between the main body portion and the second lower mold;
A liquid urethane resin raw material containing an inorganic or organic antibacterial agent is poured into the second cavity;
The second lower mold is heated to harden the urethane resin raw material, thereby forming the antibacterial layer.

上記した本発明の製造方法において、
前記抗菌剤の比重は、前記ウレタン樹脂原料の比重より大きくてもよい。
In the above-mentioned production method of the present invention,
The specific gravity of the antibacterial agent may be greater than the specific gravity of the urethane resin raw material.

上記した本発明の製造方法において、
前記ウレタン樹脂原料は二種の液体を混合してから前記第二キャビティに流し込む二液型であってもよい。
In the above-mentioned production method of the present invention,
The urethane resin raw material may be a two-liquid type in which two kinds of liquids are mixed and then poured into the second cavity.

上記した本発明の製造方法において、
前記第二キャビティに流し込む前記ウレタン樹脂原料の粘度が20mPa・s以上150mPa・s未満であってもよい。
In the above-mentioned production method of the present invention,
The viscosity of the urethane resin raw material poured into the second cavity may be 20 mPa·s or more and less than 150 mPa·s.

上記した本発明の製造方法において、
前記抗菌層を硬化させるための硬化時間が、前記第一キャビティ内における前記本体部の冷却時間よりも長くてもよい。
In the above-mentioned production method of the present invention,
A curing time for hardening the antimicrobial layer may be longer than a cooling time for the body portion in the first cavity.

上記した本発明の製造方法において、
前記第二キャビティに流し込む前に前記ウレタン樹脂原料を貯留するタンク内で前記抗菌剤を含む前記ウレタン樹脂原料を攪拌してもよい。
In the above-mentioned production method of the present invention,
The urethane resin raw material containing the antibacterial agent may be stirred in a tank for storing the urethane resin raw material before being poured into the second cavity.

上記した本発明の製造方法において、
前記熱可塑性樹脂はABS(アクリロニトリル・ブタジエン・スチレン)樹脂またはPC-ABS(ポリカーボネートABS)樹脂であってもよい。
In the above-mentioned production method of the present invention,
The thermoplastic resin may be an ABS (acrylonitrile butadiene styrene) resin or a PC-ABS (polycarbonate ABS) resin.

本発明の一態様によれば、
熱可塑性樹脂製の本体部と、
前記本体部の表面の少なくとも一部に設けられた抗菌層と、を有する抗菌性樹脂成形品であって、
前記抗菌層は、無機系または有機系の抗菌剤を含むウレタン樹脂で構成されており、
前記抗菌剤の平均粒径は前記抗菌層の厚みの1/1000以上1/5未満であり、
前記抗菌層の表層における前記抗菌剤の濃度が、前記抗菌層の厚み方向の中心部における前記抗菌剤の濃度より高い抗菌性樹脂成形品が提供される。
According to one aspect of the present invention,
A body portion made of a thermoplastic resin;
An antibacterial resin molded product having an antibacterial layer provided on at least a part of a surface of the main body,
The antibacterial layer is made of a urethane resin containing an inorganic or organic antibacterial agent,
the average particle size of the antibacterial agent is 1/1000 or more and less than 1/5 of the thickness of the antibacterial layer;
An antibacterial resin molded article is provided in which the concentration of the antibacterial agent in the surface layer of the antibacterial layer is higher than the concentration of the antibacterial agent in the center portion in the thickness direction of the antibacterial layer.

上記した本発明の抗菌性樹脂成形品において、
前記抗菌層の厚みは50μm以上であってもよい。
In the antibacterial resin molded article of the present invention,
The antibacterial layer may have a thickness of 50 μm or more.

上記した本発明の抗菌性樹脂成形品において、
前記抗菌剤の平均粒径が5μm以上であってもよい。
In the antibacterial resin molded article of the present invention,
The antibacterial agent may have an average particle size of 5 μm or more.

上記した本発明の抗菌性樹脂成形品において、
前記熱可塑性樹脂はABS(アクリロニトリル・ブタジエン・スチレン)樹脂またはPC-ABS(ポリカーボネートABS)樹脂であってもよい。
In the antibacterial resin molded article of the present invention,
The thermoplastic resin may be an ABS (acrylonitrile butadiene styrene) resin or a PC-ABS (polycarbonate ABS) resin.

本発明によれば、無機系および有機系いずれの抗菌剤を用いることができ、かつ、抗菌剤の利用効率の高められた抗菌性樹脂成形品およびその製造方法が提供される。 The present invention provides an antibacterial resin molded article and a method for producing the same, which can use either inorganic or organic antibacterial agents and has improved utilization efficiency of the antibacterial agent.

本発明に係る抗菌性樹脂成形品の断面図である。1 is a cross-sectional view of an antibacterial resin molded article according to the present invention. 上型と第一下型とを型閉じて第一キャビティを形成した状態を示す模式図である。1 is a schematic diagram showing a state in which an upper mold and a first lower mold are closed to form a first cavity. FIG. 第一キャビティ内に熱可塑性樹脂を流し込んで本体部を成形する様子を示す模式図である。4 is a schematic diagram showing a state in which a thermoplastic resin is poured into a first cavity to form a main body portion. FIG. 上型に本体部を保持させながら上型と第一下型とを型開きさせる様子を示す模式図である。11 is a schematic diagram showing a state in which an upper mold and a first lower mold are opened while a main body portion is held by the upper mold. FIG. 第一下型と第二下型とを交換する様子を示す模式図である。FIG. 13 is a schematic diagram showing a state in which a first lower die and a second lower die are replaced. 上型と第二下型とで形成した第二キャビティ内にウレタン樹脂原料を流し込む様子を示す模式図である。4 is a schematic diagram showing how a urethane resin raw material is poured into a second cavity formed by an upper mold and a second lower mold. FIG. ウレタン樹脂原料を硬化させて抗菌層を成形する様子を示す模式図である。FIG. 2 is a schematic diagram showing how an antibacterial layer is formed by curing a urethane resin raw material. 抗菌剤を含む液状のウレタン樹脂原料を第二キャビティ内に流し込む様子を示す図である。13 is a diagram showing the state in which a liquid urethane resin raw material containing an antibacterial agent is poured into a second cavity. FIG.

以下、本発明を実施の形態をもとに図面を参照しながら説明する。各図面に示される同一または同等の構成要素、部材、処理には、同一の符号を付するものとし、適宜重複した説明は省略する。また、実施の形態は、発明を限定するものではなく例示であって、実施の形態に記述される全ての特徴やその組合せは、必ずしも発明の本質的なものであるとは限らない。 The present invention will be described below with reference to the drawings based on the embodiments. The same or equivalent components, parts, and processes shown in each drawing will be given the same reference numerals, and duplicated descriptions will be omitted as appropriate. Furthermore, the embodiments are illustrative rather than limiting the invention, and all of the features and combinations thereof described in the embodiments are not necessarily essential to the invention.

図1は、本発明の実施形態に係る抗菌性樹脂成形品1の断面図である。図1に示したように、抗菌性樹脂成形品1は、熱可塑性樹脂製の本体部2と、本体部2の表面の少なくとも一部に設けられた抗菌層3とを有している。本体部2は、ABS(アクリロニトリル・ブタジエン・スチレン)樹脂またはPC-ABS(ポリカーボネートABS)樹脂などの熱可塑性樹脂で構成されている。抗菌層3の厚みTは50μm以上とすることが好ましい。 Figure 1 is a cross-sectional view of an antibacterial resin molded product 1 according to an embodiment of the present invention. As shown in Figure 1, the antibacterial resin molded product 1 has a body 2 made of thermoplastic resin and an antibacterial layer 3 provided on at least a portion of the surface of the body 2. The body 2 is made of a thermoplastic resin such as ABS (acrylonitrile butadiene styrene) resin or PC-ABS (polycarbonate ABS) resin. It is preferable that the thickness T of the antibacterial layer 3 is 50 μm or more.

抗菌層3は、無機系または有機系の抗菌剤4(図8参照)を含むウレタン樹脂で構成されている。抗菌剤4としては、粒子状をなす抗菌剤4を用いることができる。抗菌剤4の平均粒径は、5μm以上のものが好ましい。なお平均粒径は、レーザー散乱回折法粒度分布測定装置により、体積平均粒径(D50)として求めることができる。 The antibacterial layer 3 is composed of a urethane resin containing an inorganic or organic antibacterial agent 4 (see Figure 8). A particulate antibacterial agent 4 can be used as the antibacterial agent 4. The average particle size of the antibacterial agent 4 is preferably 5 μm or more. The average particle size can be determined as the volume average particle size (D50) using a laser scattering diffraction method particle size distribution measuring device.

粒子状の抗菌剤4として、例えば、銀担持無機系抗菌剤や、銅担持無機系抗菌剤などの無機系の抗菌剤を用いることができる。例えば無機系抗菌剤として、以下を採用できる。
担体としてリン酸ジルコニア、リン酸アルミニウム、ヒドロキシアパタイト、リン酸カルシウムなどのリン酸塩が用いられた銀担持無機系抗菌剤・銅担持無機系抗菌剤、
担体としてゼオライト、シリカゲルなどのケイ酸塩が用いられた銀担持無機系抗菌剤・銅担持無機系抗菌剤、
担体としてガラスや活性炭、炭素繊維などが用いられた銀担持無機系抗菌剤・銅担持無機系抗菌剤
For example, inorganic antibacterial agents such as a silver-supported inorganic antibacterial agent and a copper-supported inorganic antibacterial agent can be used as the particulate antibacterial agent 4. For example, the following can be used as the inorganic antibacterial agent.
Silver-supported inorganic antibacterial agents and copper-supported inorganic antibacterial agents using phosphates such as zirconia phosphate, aluminum phosphate, hydroxyapatite, and calcium phosphate as carriers;
Silver-supported inorganic antibacterial agents and copper-supported inorganic antibacterial agents using silicates such as zeolite and silica gel as carriers;
Silver-supported inorganic antibacterial agents and copper-supported inorganic antibacterial agents that use glass, activated carbon, carbon fiber, etc. as carriers

あるいは、有機系の抗菌剤として以下を採用できる。
α-ブロモシンナムアルデヒドなどのアルデヒド系の抗菌剤
安息香酸ナトリウムなどのカルボン酸系の抗菌剤
2-ベンジル-4-クロロフェノールなどのフェノール系の抗菌剤
3-ヨード-2-プロビニルブチルカルバメートなどの有機ヨード系の抗菌剤
2-(4-チアゾリル)ペンツイミダゾールなどのペンツイミダゾール系の抗菌剤
2-n-オクチル-4-イソチアゾリン-3-オンなどのイソチアゾリン系の抗菌剤
2,4,5,6-テトラクロロイソフタロニトリルなどのニトリル系の抗菌剤
2,3,5,6-テトラクロル-4-(メチルスルホニル)ピリジンなどのピリジン系の抗菌剤
N,N’,N”-トリスヒドロキシエチルヘキサヒドロ-s-トリアジンなどのトリアジン系の抗菌剤
N-(フルオロジクロロメチルチオ)フタルイミドなどのN-ハロアルキルチオ系の抗菌剤
塩化ジデシルジメチルアンモニウムなどの第四アンモニウム塩系の抗菌剤
ビス(ピリジン-2-チオールーl-オキシド)亜鉛塩などのピリチオン系の抗菌剤
8-オキシキノリン銅などの有機銅系の抗菌剤
10,10’-オキシビスフェノキサアルシンなどの有機ヒ素系の抗菌剤
ワサビ、カラシ、ヒノキなどの植物由来の有機系の抗菌剤
Alternatively, the following can be employed as organic antimicrobial agents:
Aldehyde-based antibacterial agents such as α-bromocinnamaldehyde; Carboxylic acid-based antibacterial agents such as sodium benzoate; Phenol-based antibacterial agents such as 2-benzyl-4-chlorophenol; Organic iodine-based antibacterial agents such as 3-iodo-2-propyl butyl carbamate; Penzimidazole-based antibacterial agents such as 2-(4-thiazolyl)pentimidazole; Isothiazolin-based antibacterial agents such as 2-n-octyl-4-isothiazolin-3-one; Nitrile-based antibacterial agents such as 2,4,5,6-tetrachloroisophthalonitrile; Pyridine-based antibacterial agents such as 2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine; Triazine-based antibacterial agents such as N,N',N"-trishydroxyethylhexahydro-s-triazine; N-haloalkylthio-based antibacterial agents such as N-(fluorodichloromethylthio)phthalimide; Quaternary ammonium salt-based antibacterial agents such as didecyldimethylammonium chloride. Pyrithione-based antibacterial agents such as bis(pyridine-2-thiol-l-oxide) zinc salt; Organocopper-based antibacterial agents such as 8-oxyquinoline copper; Organoarsenic-based antibacterial agents such as 10,10'-oxybisphenoxaarsine; Organic antibacterial agents derived from plants such as wasabi, mustard, and cypress.

次に図2から図8を用いて、抗菌性樹脂成形品1の製造方法を説明する。
まず図2に示したように、上型10と第一下型20とを型閉じして、本体部2を形成するための第一キャビティC1を形成する。上型10と第一下型20は互いに上下方向に移動可能である。ここでは上型10は上下方向に動かず、第一下型20が上下方向に移動可能であるものとする。
Next, a method for producing the antibacterial resin molded product 1 will be described with reference to FIGS.
2, the upper mold 10 and the first lower mold 20 are closed to form a first cavity C1 for forming the main body 2. The upper mold 10 and the first lower mold 20 are movable in the vertical direction relative to each other. Here, it is assumed that the upper mold 10 does not move in the vertical direction, and the first lower mold 20 is movable in the vertical direction.

次に図3に示したように、上型10と第一下型20とによって形成された第一キャビティC1に溶融状態の熱可塑性樹脂R1を流し込む。第一キャビティC1に熱可塑性樹脂R1を充填した後、上型10および/または第一下型20を冷却して、熱可塑性樹脂R1を冷却固化させ、本体部2を成形する。 Next, as shown in FIG. 3, molten thermoplastic resin R1 is poured into the first cavity C1 formed by the upper die 10 and the first lower die 20. After the first cavity C1 is filled with the thermoplastic resin R1, the upper die 10 and/or the first lower die 20 are cooled to cool and solidify the thermoplastic resin R1, thereby forming the main body 2.

次に図4に示したように、上型10に本体部2を保持させながら上型10と第一下型20とを型開きさせる。ここでは、本体部2が冷却されて本体部2が上型10よりも収縮したことにより、本体部2が上型10に取り付いている。 Next, as shown in FIG. 4, the upper mold 10 and the first lower mold 20 are opened while the upper mold 10 holds the main body 2. Here, the main body 2 is cooled and shrinks more than the upper mold 10, so that the main body 2 is attached to the upper mold 10.

なお、上型10に本体部2を保持させる方法はこの例に限られない。本体部2に、第一下型20方向への離脱を防止するための上型10に向かって突出する突状部が設けられていてもよい。あるいは、上型10に、本体部2が第一下型20方向へ離脱することを防止するための第一キャビティC1に向かって突出する突状部が設けられていてもよい。あるいは、上型10に設けられたこのような突状部が第一キャビティC1内へ進出可能な可動ピンによって構成されていてもよい。 The method of holding the main body 2 on the upper mold 10 is not limited to this example. The main body 2 may be provided with a protrusion that protrudes toward the upper mold 10 to prevent it from escaping in the direction of the first lower mold 20. Alternatively, the upper mold 10 may be provided with a protrusion that protrudes toward the first cavity C1 to prevent the main body 2 from escaping in the direction of the first lower mold 20. Alternatively, such a protrusion provided on the upper mold 10 may be constituted by a movable pin that can advance into the first cavity C1.

図5は、第一下型20と第二下型30とを交換する様子を示す模式図である。図5に示したように、第一下型20を、上型10に保持された本体部2の温度より低温に設定した第二下型30と交換する。ここでは、上型10を左右方向に移動させて、冷却しておいた第二下型30の上方まで移動させる。第二下型30は、水冷または空冷によって本体部2の温度よりも低温にしておく。
なお、第二下型30を上型10に保持された本体部2の温度よりも低温に設定するとは、型開き時に上型10に保持された本体部2を測定して得られる温度よりも第二下型30のキャビティ面が低温になるように第二下型30を温度設定してもよい。あるいは、あらかじめ、型開き時の上型10に保持された本体部2の温度が実験的に確認されており、この温度以下となるように第二下型30の温度が設定されてもよい。あるいは、型開き時は、本体部2の温度が上型10の温度より高いため、第二下型30の温度を上型10の温度以下に設定してもよい。
Fig. 5 is a schematic diagram showing the state of replacing the first lower mold 20 with the second lower mold 30. As shown in Fig. 5, the first lower mold 20 is replaced with the second lower mold 30 set to a temperature lower than the temperature of the main body 2 held by the upper mold 10. Here, the upper mold 10 is moved in the left-right direction to above the second lower mold 30, which has been cooled. The second lower mold 30 is cooled to a temperature lower than the temperature of the main body 2 by water cooling or air cooling.
Note that setting the second lower mold 30 to a temperature lower than the temperature of the main body 2 held by the upper mold 10 may mean setting the temperature of the second lower mold 30 so that the cavity surface of the second lower mold 30 is lower than the temperature obtained by measuring the temperature of the main body 2 held by the upper mold 10 when the molds are opened. Alternatively, the temperature of the main body 2 held by the upper mold 10 when the molds are opened may be experimentally confirmed in advance, and the temperature of the second lower mold 30 may be set to be equal to or lower than this temperature. Alternatively, since the temperature of the main body 2 is higher than the temperature of the upper mold 10 when the molds are opened, the temperature of the second lower mold 30 may be set to be equal to or lower than the temperature of the upper mold 10.

次に図6に示したように、上型10と第二下型30とを型閉じして、本体部2と第二下型30との間に、抗菌層3を形成するための第二キャビティC2を形成する。上型10と第二下型30とで形成されるキャビティには、本体部2が収容される空間と、抗菌層3を形成するための第二キャビティC2とによって構成されている。このため、上型10と第二下型30とで形成されるキャビティは、本体部2を形成するための第一キャビティC1よりも大きい。 Next, as shown in FIG. 6, the upper mold 10 and the second lower mold 30 are closed to form a second cavity C2 for forming the antibacterial layer 3 between the main body portion 2 and the second lower mold 30. The cavity formed by the upper mold 10 and the second lower mold 30 is composed of a space for accommodating the main body portion 2 and the second cavity C2 for forming the antibacterial layer 3. Therefore, the cavity formed by the upper mold 10 and the second lower mold 30 is larger than the first cavity C1 for forming the main body portion 2.

次に図7に示したように、第二キャビティC2内に、抗菌剤4を含む液状のウレタン樹脂原料R2を流し込む。さらに第二下型30を加熱してウレタン樹脂原料R2を反応硬化させて抗菌層3を形成する。このようにして、本体部2の表面の少なくとも一部に抗菌層3が設けられた抗菌性樹脂成形品1が形成される。 Next, as shown in FIG. 7, liquid urethane resin raw material R2 containing antibacterial agent 4 is poured into second cavity C2. The second lower die 30 is then heated to react and harden the urethane resin raw material R2 to form antibacterial layer 3. In this way, an antibacterial resin molded product 1 is formed in which antibacterial layer 3 is provided on at least a portion of the surface of main body 2.

本実施形態の製造方法によれば、本体部2と抗菌層3とを別工程で硬化させている。抗菌層3をなすウレタン樹脂原料R2の硬化温度は100度以下であり、有機系の抗菌剤4の抗菌効果がなくなる耐熱温度よりも低温である。このため、ウレタン樹脂原料R2を硬化させて抗菌層3を形成する際に有機系の抗菌剤4の抗菌効果を保つことができる。 According to the manufacturing method of this embodiment, the main body 2 and the antibacterial layer 3 are cured in separate processes. The curing temperature of the urethane resin raw material R2 that forms the antibacterial layer 3 is 100 degrees or less, which is lower than the heat resistance temperature at which the antibacterial effect of the organic antibacterial agent 4 is lost. Therefore, the antibacterial effect of the organic antibacterial agent 4 can be maintained when the urethane resin raw material R2 is cured to form the antibacterial layer 3.

図8は、抗菌剤4を含む液状のウレタン樹脂原料R2を第二キャビティC2内に流し込む様子を示す図である。キャビティ面31付近は第二キャビティC2の厚み方向の中央よりも、第二キャビティC2内を流れる流体にかかる抵抗が大きいため、流速が遅くなる。そして、ウレタン樹脂原料R2が第二キャビティC2を流れる際は、フローフロントでのファウンテンフロー現象により粒子状の抗菌剤4は、第二キャビティC2の厚み方向の中央に留まりにくく、キャビティ面31付近にたまりやすくなる。このような理由により、本実施形態の製造方法により得られた抗菌性樹脂成形品1においては、抗菌層3の表層における抗菌剤4の濃度が、抗菌層3の厚み方向の中心部における抗菌剤4の濃度より高くなる。このため、抗菌層3の表面に抗菌剤4が露出しやすく、抗菌剤4の利用効率が高められている。
なお、抗菌剤4の平均粒径は抗菌層3の厚みの1/1000以上1/5であることが好ましい。抗菌剤4の平均粒径が1/1000未満であると、抗菌剤4がウレタン樹脂原料R内に分散し難くなる。抗菌剤4の平均粒径が1/5より大きいと、第二キャビティC2を抗菌剤4がウレタン樹脂原料R2によって運ばれにくくなる。
8 is a diagram showing a state in which the liquid urethane resin raw material R2 containing the antibacterial agent 4 is poured into the second cavity C2. The flow rate is slower near the cavity surface 31 than at the center of the thickness direction of the second cavity C2 because the resistance to the fluid flowing in the second cavity C2 is greater near the cavity surface 31. When the urethane resin raw material R2 flows through the second cavity C2, the particulate antibacterial agent 4 is less likely to remain in the center of the thickness direction of the second cavity C2 due to the fountain flow phenomenon at the flow front, and is more likely to accumulate near the cavity surface 31. For this reason, in the antibacterial resin molded product 1 obtained by the manufacturing method of this embodiment, the concentration of the antibacterial agent 4 in the surface layer of the antibacterial layer 3 is higher than the concentration of the antibacterial agent 4 in the center of the thickness direction of the antibacterial layer 3. For this reason, the antibacterial agent 4 is more likely to be exposed on the surface of the antibacterial layer 3, and the utilization efficiency of the antibacterial agent 4 is improved.
The average particle size of the antibacterial agent 4 is preferably 1/1000 or more and 1/5 of the thickness of the antibacterial layer 3. If the average particle size of the antibacterial agent 4 is less than 1/1000, the antibacterial agent 4 becomes difficult to disperse in the urethane resin raw material R. If the average particle size of the antibacterial agent 4 is more than 1/5, the antibacterial agent 4 becomes difficult to be carried through the second cavity C2 by the urethane resin raw material R2.

また抗菌剤4の比重はウレタン樹脂原料R2の比重よりも大きいことが好ましい。抗菌剤4の比重がウレタン樹脂原料R2の比重よりも大きいと、抗菌層3を形成する工程において、第二キャビティC2の下面を構成している第二下型30のキャビティ面31に抗菌剤4がたまりやすい。そのため、抗菌層3の表面に抗菌剤4を位置させやすくなる。抗菌剤4の比重はウレタン樹脂原料R2の比重の1.5倍以上であることが好ましい。さらに好ましくは抗菌剤4の比重はウレタン樹脂原料R2の比重の2倍以上であることが好ましい。 The specific gravity of the antibacterial agent 4 is preferably greater than that of the urethane resin raw material R2. If the specific gravity of the antibacterial agent 4 is greater than that of the urethane resin raw material R2, the antibacterial agent 4 is likely to accumulate on the cavity surface 31 of the second lower mold 30 that constitutes the lower surface of the second cavity C2 in the process of forming the antibacterial layer 3. This makes it easier to position the antibacterial agent 4 on the surface of the antibacterial layer 3. The specific gravity of the antibacterial agent 4 is preferably 1.5 times or more the specific gravity of the urethane resin raw material R2. More preferably, the specific gravity of the antibacterial agent 4 is more than twice the specific gravity of the urethane resin raw material R2.

またウレタン樹脂原料R2は二種の液体を混合してから第二キャビティC2に流し込む二液型であることが好ましい。二液型のウレタン樹脂原料R2は、二種類の液体の配合比率を調整するなどしてウレタン樹脂原料R2の硬化速度を調整することができる。このため、抗菌剤4が表面に露出するように抗菌剤4がウレタン樹脂原料R2の中で移動してからウレタン樹脂原料R2が硬化するようにその硬化速度を調節することができる。 The urethane resin raw material R2 is preferably a two-liquid type in which two types of liquid are mixed and then poured into the second cavity C2. The two-liquid type urethane resin raw material R2 allows the hardening speed of the urethane resin raw material R2 to be adjusted by, for example, adjusting the blending ratio of the two types of liquid. Therefore, the hardening speed can be adjusted so that the antibacterial agent 4 moves within the urethane resin raw material R2 so that the antibacterial agent 4 is exposed to the surface before the urethane resin raw material R2 hardens.

第二キャビティC2に流し込むウレタン樹脂原料R2の粘度は20mPa・s以上150mPa・s未満であることが好ましい。ウレタン樹脂原料R2の粘度が20mPa・sより小さいと、抗菌剤4を含むウレタン樹脂原料R2を攪拌しても、タンク32内で抗菌剤4がすぐに沈降してしまい、流し込むウレタン樹脂原料R2の抗菌剤4濃度がばらつき、抗菌層3に抗菌剤4が偏ってしまいやすい。ウレタン樹脂原料R2の粘度が150mPa・sより大きいと、第二キャビティC2内をウレタン樹脂原料R2が流れにくくなる。また、抗菌剤4がウレタン樹脂原料R2に混ざりにくい。さらに、抗菌剤4が第二キャビティC2内で沈降し難くなる。 The viscosity of the urethane resin raw material R2 poured into the second cavity C2 is preferably 20 mPa·s or more and less than 150 mPa·s. If the viscosity of the urethane resin raw material R2 is less than 20 mPa·s, the antibacterial agent 4 will settle quickly in the tank 32 even if the urethane resin raw material R2 containing the antibacterial agent 4 is stirred, and the concentration of the antibacterial agent 4 in the poured urethane resin raw material R2 will vary, and the antibacterial agent 4 will tend to be concentrated in the antibacterial layer 3. If the viscosity of the urethane resin raw material R2 is greater than 150 mPa·s, the urethane resin raw material R2 will not flow easily in the second cavity C2. In addition, the antibacterial agent 4 will not easily mix with the urethane resin raw material R2. Furthermore, the antibacterial agent 4 will not easily settle in the second cavity C2.

図7に示した工程における抗菌層3を硬化させるための硬化時間が、図3に示した工程における第一キャビティC1内における本体部2の冷却時間よりも長いことが好ましい。抗菌層3の硬化時間を長くするほど、抗菌剤4がウレタン樹脂原料R2の中で移動(沈降)する時間を確保しやすいからである。 The curing time for hardening the antibacterial layer 3 in the process shown in FIG. 7 is preferably longer than the cooling time for the main body portion 2 in the first cavity C1 in the process shown in FIG. 3. This is because the longer the curing time for the antibacterial layer 3, the easier it is to ensure that the antibacterial agent 4 has time to move (settle) in the urethane resin raw material R2.

なお、ウレタン樹脂原料R2に粒子状の抗菌剤4をなるべく均等に分散させた状態で、ウレタン樹脂原料R2を第二キャビティC2に流し込むことが好ましい。このため、第二キャビティC2に流し込む前にウレタン樹脂原料R2を貯留するタンク32(図6参照)内で抗菌剤4を含むウレタン樹脂原料R2を攪拌することが好ましい。 It is preferable to pour the urethane resin raw material R2 into the second cavity C2 with the particulate antibacterial agent 4 dispersed as evenly as possible in the urethane resin raw material R2. For this reason, it is preferable to stir the urethane resin raw material R2 containing the antibacterial agent 4 in the tank 32 (see FIG. 6) that stores the urethane resin raw material R2 before pouring it into the second cavity C2.

なお、連続して抗菌性樹脂成形品1を製造する場合は、図7に示した状態から型開きをして抗菌性樹脂成形品1を脱型し、上型10を左右方向に移動させて第一下型20の上方まで移動させた後、第二下型30の冷却を開始して図5に示した工程に備えておく。 When manufacturing antibacterial resin molded articles 1 continuously, the mold is opened from the state shown in FIG. 7 to remove the antibacterial resin molded article 1, and the upper mold 10 is moved left and right to above the first lower mold 20, after which cooling of the second lower mold 30 is started to prepare for the process shown in FIG. 5.

また、上述した説明においては、上型10が左右方向に移動可能であり、第一下型20および第二下型30が上下方向に移動可能な例を説明したが、本発明はこれに限られない。上型10は左右方向および上下方向に移動可能であり、第一下型20および第二下型30が固定されていてもよい。あるいは、上型10は固定されており、第一下型20および第二下型30が左右方向および上下方向に移動可能であってもよい。 In the above explanation, an example was described in which the upper mold 10 is movable in the left-right direction and the first lower mold 20 and the second lower mold 30 are movable in the up-down direction, but the present invention is not limited to this. The upper mold 10 may be movable in the left-right direction and the up-down direction, and the first lower mold 20 and the second lower mold 30 may be fixed. Alternatively, the upper mold 10 may be fixed, and the first lower mold 20 and the second lower mold 30 may be movable in the left-right direction and the up-down direction.

なお、本発明は、上述した実施形態に限定されず、適宜、変形、改良等が自在である。
その他、上述した実施形態における各構成要素の材質、形状、寸法、数値、形態、数、配置場所等は、本発明を達成できるものであれば任意であり、限定されない。
The present invention is not limited to the above-described embodiment, and can be modified and improved as appropriate.
Furthermore, the material, shape, size, value, form, number, location, and the like of each component in the above-described embodiment are arbitrary and not limited as long as they can achieve the present invention.

1 抗菌性樹脂成形品
2 本体部
3 抗菌層
4 抗菌剤
10 上型
20 第一下型
30 第二下型
31 キャビティ面
32 (ウレタン樹脂原料を貯留する)タンク
C1 第一キャビティ
C2 第二キャビティ
R1 熱可塑性樹脂
R2 ウレタン樹脂原料
Reference Signs List 1 Antibacterial resin molded product 2 Main body 3 Antibacterial layer 4 Antibacterial agent 10 Upper mold 20 First lower mold 30 Second lower mold 31 Cavity surface 32 (Storage of urethane resin raw material) Tank C1 First cavity C2 Second cavity R1 Thermoplastic resin R2 Urethane resin raw material

Claims (10)

熱可塑性樹脂製の本体部と、前記本体部の表面の少なくとも一部に設けられた抗菌層と、を有する抗菌性樹脂成形品の製造方法であって、
上下に開閉する上型および第一下型を型閉じして前記本体部を形成するための第一キャビティを形成し、前記第一キャビティに熱可塑性樹脂を流し込み、
型閉じした前記上型および前記第一下型内で前記熱可塑性樹脂を冷却固化させて前記本体部を成形し、
前記上型に前記本体部を保持させながら、前記上型および前記第一下型を型開きさせ、
前記第一下型を前記上型に保持された前記本体部の温度より低温にした第二下型と交換し、
前記上型および前記第二下型を型閉じして、前記本体部と前記第二下型との間に前記抗菌層を形成するための第二キャビティを形成し、
前記第二キャビティ内に、無機系または有機系の抗菌剤を含む液状のウレタン樹脂原料を流し込み、
前記第二下型を加熱して前記ウレタン樹脂原料を硬化させて前記抗菌層を成形する、抗菌性樹脂成形品の製造方法。
A method for producing an antibacterial resin molded product having a thermoplastic resin body and an antibacterial layer provided on at least a portion of a surface of the body, comprising:
An upper mold and a first lower mold that open and close vertically are closed to form a first cavity for forming the main body portion, and a thermoplastic resin is poured into the first cavity;
The thermoplastic resin is cooled and solidified within the closed upper mold and the first lower mold to mold the main body portion;
While the main body portion is held by the upper die, the upper die and the first lower die are opened;
replacing the first lower die with a second lower die whose temperature is lower than the temperature of the main body portion held by the upper die;
The upper mold and the second lower mold are closed to form a second cavity for forming the antibacterial layer between the main body portion and the second lower mold;
A liquid urethane resin raw material containing an inorganic or organic antibacterial agent is poured into the second cavity;
The second lower mold is heated to harden the urethane resin raw material and form the antibacterial layer.
前記抗菌剤の比重は、前記ウレタン樹脂原料の比重より大きい請求項1記載の抗菌性樹脂成形品の製造方法。 The method for producing an antibacterial resin molded product according to claim 1, wherein the specific gravity of the antibacterial agent is greater than the specific gravity of the urethane resin raw material. 前記ウレタン樹脂原料は二種の液体を混合してから前記第二キャビティに流し込む二液型である、請求項1に記載の抗菌性樹脂成形品の製造方法。 The method for manufacturing antibacterial resin molded products according to claim 1, wherein the urethane resin raw material is a two-liquid type in which two types of liquid are mixed and then poured into the second cavity. 前記第二キャビティに流し込む前記ウレタン樹脂原料の粘度が20mPa・s以上150mPa・s未満である、請求項1に記載の抗菌性樹脂成形品の製造方法。 The method for producing an antibacterial resin molded product according to claim 1, wherein the viscosity of the urethane resin raw material poured into the second cavity is 20 mPa·s or more and less than 150 mPa·s. 前記抗菌層を硬化させるための硬化時間が、前記第一キャビティ内における前記本体部の冷却時間よりも長い、請求項1に記載の抗菌性樹脂成形品の製造方法。 The method for manufacturing an antibacterial resin molded product according to claim 1, wherein the curing time for curing the antibacterial layer is longer than the cooling time of the main body portion in the first cavity. 前記第二キャビティに流し込む前に前記ウレタン樹脂原料を貯留するタンク内で前記抗菌剤を含む前記ウレタン樹脂原料を攪拌する、請求項1に記載の抗菌性樹脂成形品の製造方法。 The method for producing an antibacterial resin molded product according to claim 1, wherein the urethane resin raw material containing the antibacterial agent is stirred in a tank that stores the urethane resin raw material before pouring it into the second cavity. 前記熱可塑性樹脂はABS(アクリロニトリル・ブタジエン・スチレン)樹脂またはPC-ABS(ポリカーボネートABS)樹脂である、請求項1に記載の抗菌性樹脂成形品の製造方法。 The method for manufacturing antibacterial resin molded products according to claim 1, wherein the thermoplastic resin is ABS (acrylonitrile butadiene styrene) resin or PC-ABS (polycarbonate ABS) resin. 熱可塑性樹脂製の本体部と、
前記本体部の表面の少なくとも一部に設けられた抗菌層と、を有する抗菌性樹脂成形品であって、
前記抗菌層は、無機系または有機系の抗菌剤を含むウレタン樹脂で構成されており、
前記抗菌剤の平均粒径は前記抗菌層の厚みの1/1000以上1/5未満であり、
前記抗菌層の表層における前記抗菌剤の濃度が、前記抗菌層の厚み方向の中心部における前記抗菌剤の濃度より高く、
前記熱可塑性樹脂はABS(アクリロニトリル・ブタジエン・スチレン)樹脂またはPC-ABS(ポリカーボネートABS)樹脂である、抗菌性樹脂成形品。
A body portion made of a thermoplastic resin;
An antibacterial resin molded product having an antibacterial layer provided on at least a part of a surface of the main body,
The antibacterial layer is made of a urethane resin containing an inorganic or organic antibacterial agent,
the average particle size of the antibacterial agent is 1/1000 or more and less than 1/5 of the thickness of the antibacterial layer;
a concentration of the antibacterial agent in a surface layer of the antibacterial layer is higher than a concentration of the antibacterial agent in a center portion in a thickness direction of the antibacterial layer;
The antibacterial resin molded product , wherein the thermoplastic resin is ABS (acrylonitrile butadiene styrene) resin or PC-ABS (polycarbonate ABS) resin .
前記抗菌層の厚みは50μm以上である、請求項8に記載の抗菌性樹脂成形品。 The antibacterial resin molded product according to claim 8, wherein the antibacterial layer has a thickness of 50 μm or more. 前記抗菌剤の平均粒径が5μm以上である、請求項8に記載の抗菌性樹脂成形品。 The antibacterial resin molded product according to claim 8, wherein the average particle size of the antibacterial agent is 5 μm or more.
JP2021023185A 2021-02-17 2021-02-17 Antibacterial resin molded product and its manufacturing method Active JP7594458B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021023185A JP7594458B2 (en) 2021-02-17 2021-02-17 Antibacterial resin molded product and its manufacturing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2021023185A JP7594458B2 (en) 2021-02-17 2021-02-17 Antibacterial resin molded product and its manufacturing method

Publications (2)

Publication Number Publication Date
JP2022125544A JP2022125544A (en) 2022-08-29
JP7594458B2 true JP7594458B2 (en) 2024-12-04

Family

ID=83058475

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021023185A Active JP7594458B2 (en) 2021-02-17 2021-02-17 Antibacterial resin molded product and its manufacturing method

Country Status (1)

Country Link
JP (1) JP7594458B2 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002316323A (en) 2001-04-19 2002-10-29 Sanko Gosei Ltd Method and apparatus for replacing mold of resin molding machine
JP2004058564A (en) 2002-07-31 2004-02-26 Nippon Plast Co Ltd Manufacturing method of RIM molded product
JP2006103187A (en) 2004-10-06 2006-04-20 Inax Corp Manufacturing method of warm feeling member
US20140203475A1 (en) 2011-04-27 2014-07-24 Global Ip Holdings, Llc Antimicrobial, molded laminate shopping cart part and method of manufacturing same
JP2017088586A (en) 2015-11-17 2017-05-25 イビデン株式会社 Decorative sheet
JP2017176451A (en) 2016-03-30 2017-10-05 株式会社Lixil toilet seat
JP2018203898A (en) 2017-06-06 2018-12-27 リンテック株式会社 Adhesive film and manufacturing method of adhesive film

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10264205A (en) * 1997-03-24 1998-10-06 Dainippon Printing Co Ltd Method for producing antibacterial resin molded article, and antibacterial resin molded article
KR100912265B1 (en) * 2007-04-10 2009-08-17 동양케미칼주식회사 Thermoplastic Polyurethane Antibacterial Cutting Board and Manufacturing Method Thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002316323A (en) 2001-04-19 2002-10-29 Sanko Gosei Ltd Method and apparatus for replacing mold of resin molding machine
JP2004058564A (en) 2002-07-31 2004-02-26 Nippon Plast Co Ltd Manufacturing method of RIM molded product
JP2006103187A (en) 2004-10-06 2006-04-20 Inax Corp Manufacturing method of warm feeling member
US20140203475A1 (en) 2011-04-27 2014-07-24 Global Ip Holdings, Llc Antimicrobial, molded laminate shopping cart part and method of manufacturing same
JP2017088586A (en) 2015-11-17 2017-05-25 イビデン株式会社 Decorative sheet
JP2017176451A (en) 2016-03-30 2017-10-05 株式会社Lixil toilet seat
JP2018203898A (en) 2017-06-06 2018-12-27 リンテック株式会社 Adhesive film and manufacturing method of adhesive film

Also Published As

Publication number Publication date
JP2022125544A (en) 2022-08-29

Similar Documents

Publication Publication Date Title
KR102048732B1 (en) Process for producing a moulding using a water-soluble casting mould and material system for the production thereof
CN103228710B (en) Thermoplastic molding composition containing microencapsulated latent heat storage material
CN106903851B (en) Injection molding method for producing a molded part, molded part produced by injection molding, and injection mold
AU2017253536B2 (en) Bead polymer made of hard phase with domains of a soft phase
US3692551A (en) Core for use in pressure molding
US4840219A (en) Mixture and method for preparing casting cores and cores prepared thereby
EP2163328A1 (en) Core or foundry sand coated and/or mixed with soluble glass with a water content in the area of >= approx. 0.25 weight % to approx 0.9 weight %
CN110293654A (en) For injection molding reusable mold and forming method
JP7594458B2 (en) Antibacterial resin molded product and its manufacturing method
Adams et al. Motion control for uniaxial rotational molding
AT516548B1 (en) Thermoplastic casting material
CN206170637U (en) Three -dimensional inkjet printer and three -dimensional body
JP2018504513A (en) Flexible metal polymer composite
IT202000026221A1 (en) METHOD AND KIT FOR ANCHORING TO A WORK SURFACE OF ITEMS MADE THROUGH THREE-DIMENSIONAL PRINTING
IL31663A (en) Molded plastic articles and method of making the same
US20100229682A1 (en) Cold cast mass element
US8142706B2 (en) Device and method for injection molding product having hydrophobic pattern
JPS60500906A (en) Pressure molding method using salt core and composition for producing core
JP6878777B2 (en) Overmolded resin composition and overmolded integrally molded product
Alzahrani An Investigation of the Effect of Rheo-Printing Technology on Big Area Additive Manufacturing
CN108405830B (en) A kind of fusion cast process method of metal handicrafts
EP3800031B1 (en) Method of injection moulding an injection-mouldable thermoplastic material
JP6817577B2 (en) Manufacturing method of resin molded products
JP2019130843A (en) Mold and method for producing resin molded product
Torres Rotational moulding of polymers

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231018

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240618

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240814

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241112

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241122

R150 Certificate of patent or registration of utility model

Ref document number: 7594458

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150